Helping more people survive cancer is the aim of everything we do. Read stories from people who have been affected by pancreatic cancer, and how research has made a difference to them.
Retired lab manager Peter Breaden, who lives in Southport, was diagnosed with pancreatic cancer in 2010. He took part in ESPAC-4, a CRUK-funded clinical trial that has led to a call for a new standard treatment for people with pancreatic cancer who have had surgery. "It was very satisfying to take part in something that was so successful - I found out that the combination of drugs I was given almost doubled the number of people surviving five years after the operation, compared to using one of the drugs alone."
From studying the biology of pancreatic cancer cells in the lab to leading clinical trials testing cutting-edge treatments, our researchers are working hard to ensure more people survive pancreatic cancer.
Thanks to research, we've helped change the outlook for people with pancreatic cancer.
Want to find more information about our research or pancreatic cancer?
